Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-06-25Clinical Trial Update: Regorafenib Assessment in Refractory Advanced Colorectal Cancer(RegARd-C) [Phase 2]
Phase 2 trial update for regorafenib in refractory advanced colorectal cancer (RegARd-C) completed.
-
CLINICAL_TRIALS trial_result · 2019-06-24Clinical Trial Update: A Phase I/II Study for the Safety and Efficacy of Panitumumab in Combination With TAS-102 for Patients With Colorectal Cancer [Phase 1, Phase 2]
Phase I/II trial evaluating safety and efficacy of panitumumab combined with TAS-102 in colorectal cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-06-21Clinical Trial Update: A Trial of CXD101 in Combination With Nivolumab in Patients With Metastatic Microsatellite-Stable Colorectal Cancer [Phase 1, Phase 2]
Clinical trial update for CXD101 plus nivolumab in metastatic microsatellite-stable colorectal cancer (Phase 1/2).
-
FDA approval · 2019-06-21FDA Approved: CAPECITABINE — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical Industries' original application for Capecitabine, granting a generic version of the cancer drug Capecit…
-
CLINICAL_TRIALS trial_result · 2019-06-18Clinical Trial Update: A Study to Investigate Efficacy and Safety of Cobimetinib Plus Atezolizumab and Atezolizumab Monotherapy Versus Regorafenib in Participants With Metastatic Colorectal Adenocarcinoma (COTEZO IMblaze370) [Phase 3]
Phase 3 trial evaluating cobimetinib plus atezolizumab and atezolizumab alone versus regorafenib in metastatic colorectal adenocarcinoma; st…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-06-18Clinical Trial Update: A Phase III Clinical Study of Napabucasin (GB201) Plus FOLFIRI in Adult Patients With Metastatic Colorectal Cancer [Phase 3]
Phase III clinical trial investigating napabucasin (GB201) plus FOLFIRI in adults with previously treated metastatic colorectal cancer.
-
FDA approval · 2019-05-24FDA Approved: BRAFTOVI — Supplemental Application (Array BioPharma Inc.)
The FDA approved a supplemental application for BRAFTOVI (encorafenib) submitted by Array BioPharma Inc.
-
CLINICAL_TRIALS trial_result · 2019-05-23Clinical Trial Update: Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy [Phase 3]
Phase 3 trial evaluating calcium gluconate and magnesium sulfate to prevent neurotoxicity in patients with colorectal cancer receiving oxali…
-
CLINICAL_TRIALS trial_result · 2019-05-21Clinical Trial Update: Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies [Phase 3]
This Phase 3 study evaluates TAS-102 in metastatic colorectal cancer refractory to standard chemotherapies and has completed with results po…
-
CLINICAL_TRIALS trial_result · 2019-05-21Clinical Trial Update: Study of Anlotinib in Patients With Metastatic Colorectal Cancer（mCRC）(ALTER0703) [Phase 2, Phase 3]
A clinical trial update for anlotinib in metastatic colorectal cancer (ALTER0703) across Phase 2 and Phase 3, with the study status noted as…
-
CLINICAL_TRIALS trial_result · 2019-05-17Clinical Trial Update: Fluorouracil and Oxaliplatin With or Without Panitumumab In Treating Patients With High-Risk Colon Cancer That Can Be Removed by Surgery [Phase 2, Phase 3]
Phase 2/3 trial assessing fluorouracil and oxaliplatin with or without panitumumab in high-risk, resectable colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2019-05-15Clinical Trial Update: Rectal Reconstruction in Treating Patients Who Are Undergoing Surgery for Rectal Cancer [Phase 3]
A Phase 3 clinical trial investigating rectal reconstruction in patients undergoing rectal cancer surgery has completed.
-
CLINICAL_TRIALS trial_result · 2019-05-15Clinical Trial Update: External-Beam Radiation Therapy, Capecitabine, and Sorafenib in Treating Patients With Locally Advanced Rectal Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating external-beam radiation therapy, capecitabine, and sorafenib in locally advanced rectal cancer.
-
CLINICAL_TRIALS trial_result · 2019-05-14Clinical Trial Update: A Study of Perioperative Chemotherapy Plus Panitumumab in Patients With Colorectal Cancer Liver Metastases [Phase 2]
Phase 2 clinical trial update evaluating perioperative chemotherapy plus panitumumab in patients with colorectal cancer liver metastases has…
-
CLINICAL_TRIALS trial_result · 2019-05-10Clinical Trial Update: Genistein in Treatment of Metastatic Colorectal Cancer [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating genistein for metastatic colorectal cancer (colon and rectal cancer) with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-05-07Clinical Trial Update: Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer [Phase 2]
Phase 2 trial evaluating dual EGFR inhibition with erlotinib and panitumumab, with or without chemotherapy, in advanced colorectal cancer; r…
-
CLINICAL_TRIALS trial_result · 2019-04-25Clinical Trial Update: Phase II Study of Toripalimab Plus Stereotactic Body Radiotherapy in Colorectal Cancer Patients With Oligometastasis [Phase 2]
Phase II study evaluating toripalimab with stereotactic body radiotherapy in metastatic colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2019-04-24Clinical Trial Update: Mebendazole as Adjuvant Treatment for Colon Cancer [Phase 3]
Phase 3 clinical trial evaluating mebendazole as adjuvant treatment for colorectal cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2019-04-23Clinical Trial Update: Strategies and Opportunities to Stop Colon Cancer in Priority Populations [NA]
A completed clinical trial update focusing on strategies to stop colon cancer in priority populations; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-22Clinical Trial Update: Regorafenib in Subjects With Metastatic Colorectal Cancer (mCRC) Who Have Progressed After Standard Therapy [Phase 3]
Phase 3 clinical trial update evaluating regorafenib in metastatic colorectal cancer after progression on standard therapy.
-
CLINICAL_TRIALS trial_result · 2019-04-18Clinical Trial Update: FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer [Phase 1, Phase 2]
APhase 1/Phase 2 clinical trial evaluating FOLFOX with Bevacizumab and Hydroxychloroquine in colorectal cancer (rectal/colon cancer; include…
-
CLINICAL_TRIALS trial_result · 2019-04-17Clinical Trial Update: Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma [Phase 2]
Phase 2 trial of simtuzumab with FOLFIRI as second-line therapy in colorectal adenocarcinoma has terminated; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: A Study Evaluating S 95005 Plus Bevacizumab and Capecitabine Plus Bevacizumab in Patients With Previously Untreated Colorectal Cancer Who Are Non-eligible for Intensive Therapy [Phase 2]
Phase 2 study evaluating S 95005 plus bevacizumab and capecitabine plus bevacizumab in previously untreated metastatic colorectal cancer pat…
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Camrelizumab(SHR-1210) Combined With Apatinib in the Treatment of Advanced Metastatic Colorectal Cancer [Phase 2]
Phase 2 trial evaluating camrelizumab combined with apatinib for advanced metastatic colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer [Phase 1, Phase 2]
Phase 1/2 trial of PANVAC-V and PANVAC-F vaccines with sargramostim in advanced cancers (adenocarcinoma, colorectal cancer; other listed con…